virus
fast
evolv
pathogen
continu
adapt
highli
variabl
environ
live
reproduc
strategi
devot
inhibit
viru
replic
control
spread
among
host
need
cope
extrem
heterogen
popul
potenti
avoid
medic
intervent
comput
techniqu
phylogenet
method
broaden
pictur
viral
evolut
time
space
mathemat
model
contribut
substanti
progress
unravel
dynam
viru
replic
fit
virul
integr
multipl
comput
mathemat
approach
experiment
data
help
predict
behavior
viral
pathogen
anticip
escap
dynam
piec
inform
play
critic
role
aspect
vaccin
develop
viral
strain
select
vaccin
ration
attenu
virus
review
sever
aspect
viral
evolut
address
quantit
discuss
comput
method
potenti
improv
vaccin
design
virus
intracellular
parasit
need
cellular
machineri
host
reproduc
potenti
gener
huge
popul
size
short
gener
time
virus
gener
rna
virus
particular
exist
genet
heterogen
popul
errorpron
replic
featur
make
evolut
virus
phenomenon
observ
short
time
scale
week
month
consequ
extrem
viral
evolutionari
dynam
tremend
import
diseas
control
prevent
exampl
influenza
vaccin
need
updat
everi
year
viral
variant
develop
resist
antivir
drug
mild
viral
strain
turn
virul
one
spontan
global
health
care
issu
other
aris
rapid
evolut
virus
molecular
profil
techniqu
includ
dna
sequenc
produc
enorm
amount
data
viral
spread
genet
divers
infect
dynam
integr
analysi
data
provid
valuabl
inform
evolut
viral
pathogen
mathemat
statist
comput
method
necessari
deal
larg
data
set
predict
phenotyp
form
genet
data
ultim
use
vaccin
develop
review
summar
comput
mathemat
techniqu
play
critic
role
understand
viral
evolut
vaccin
design
specif
discuss
phylogenet
method
vaccin
strain
select
statist
model
evolutionari
escap
select
immun
pressur
viru
dynam
model
therapeut
vaccin
attenu
strategi
major
exampl
influenza
human
immunodefici
viru
hiv
footandmouth
diseas
viru
fmdv
rna
virus
great
medic
veterinari
import
studi
extens
also
discuss
current
approv
experiment
methodolog
employ
develop
antivir
vaccin
vaccin
develop
deal
four
import
trait
viral
evolut
virul
fit
divers
dynam
one
concept
subject
intens
studi
still
difficult
predict
probabl
complex
trait
intrins
stochast
evolutionari
process
progress
understand
interplay
factor
depend
quantit
descript
predict
model
thu
mathemat
evolutionari
model
like
play
increasingli
import
role
develop
new
vaccin
control
viral
diseas
quantit
descript
viral
evolut
necessari
monitor
spread
viral
pandem
develop
effect
therapi
vaccin
virus
threat
human
health
also
provid
attract
model
system
evolutionari
studi
due
short
genom
larg
popul
size
high
genet
divers
extrem
replic
dynam
rna
virus
exampl
allow
observ
signific
evolutionari
chang
time
hypothes
theori
evolutionari
mechan
often
test
directli
measur
evolv
virus
mutat
rate
rna
virus
million
time
larger
human
mutat
rate
thu
rna
virus
display
huge
genet
divers
featur
critic
surviv
viru
viru
popul
expos
fluctuat
environ
migrat
differ
organ
tissu
host
organ
expos
immun
respons
mount
host
transmiss
new
host
typic
associ
travers
variou
tissu
face
new
immun
respons
therefor
repres
major
bottleneck
viru
popul
genet
divers
rna
virus
make
like
adapt
variant
preexist
popul
even
select
pressur
chang
divers
viru
popul
determin
evolutionari
fate
select
seem
oper
popul
level
rather
level
individu
virus
idea
origin
develop
selfrepl
rna
molecul
term
quasispeci
theori
appli
rna
virus
one
predict
quasispeci
theori
exist
upper
bound
mutat
rate
beyond
popul
maintain
essenti
genet
inform
mani
rna
virus
appear
mutat
rate
close
error
threshold
evolutionari
dynam
viral
infecti
diseas
analyz
consider
detail
today
owe
advanc
highthroughput
dna
sequenc
technolog
statist
comput
model
data
viral
evolut
occur
differ
tempor
spatial
scale
shape
differ
ecolog
process
within
host
integr
model
effort
across
scale
make
use
phylogenet
popul
genet
viru
dynam
epidemiolog
method
term
phylodynam
approach
applic
techniqu
enabl
reconstruct
molecular
origin
hiv
pandem
explan
influenza
epidem
interplay
natur
select
migrat
compar
viral
dna
sequenc
heart
phylodynam
approach
gener
studi
correl
evolut
among
genotyp
phenotyp
trait
trait
environ
across
speci
known
compar
method
extrem
success
analyz
dna
sequenc
data
basi
predict
phenotyp
protein
structur
function
genotyp
case
rna
virus
display
larg
genet
divers
host
differ
viral
quasispeci
take
role
differ
speci
tradit
applic
compar
method
viral
phenotyp
interest
includ
immunolog
escap
drug
resist
vaccin
develop
consid
one
biggest
achiev
modern
medicin
bacteri
famili
share
common
biochem
featur
surfac
lipopolysacharid
therefor
treat
common
drug
antibiot
virus
typic
differ
enough
famili
even
insid
famili
make
develop
broadli
applic
antivir
drug
challeng
exampl
base
analogu
ribavirin
alon
combin
interferon
proven
act
antivir
compound
broad
activ
clinic
treatment
infect
hepat
c
viru
hcv
hepat
b
viru
hbv
respiratori
syncyti
viru
rsv
overal
antivir
drug
target
viral
protein
current
approv
use
human
virus
fought
chemic
compound
includ
hiv
influenza
viru
rsv
hcv
hbv
herp
virus
includ
herp
simplex
viru
varicellazost
viru
vzv
cytomegaloviru
howev
current
vast
major
virus
control
today
approv
compound
frequent
even
subgroup
insid
viral
speci
drug
sensit
exampl
season
influenza
viru
present
natur
resist
oseltamivir
effici
antivir
compound
usual
hamper
gener
drug
resist
virus
moreov
compound
may
help
control
infect
rare
viru
complet
clear
host
organ
contrast
vaccin
boost
immun
system
respons
principl
achiev
complet
clearanc
viru
infect
host
therefor
vaccin
consid
best
weapon
fight
virus
gener
idea
vaccin
resembl
viral
infect
avoid
associ
patholog
sever
strategi
address
goal
vari
efficaci
current
approv
viral
vaccin
use
human
list
tabl
result
one
three
main
type
vaccin
design
strategi
refer
live
attenu
vaccin
ii
inactiv
vaccin
iii
recombin
vaccin
peptidederiv
vaccin
live
attenu
vaccin
lav
immun
lav
prove
effici
vaccin
strategi
date
lav
prepar
includ
virus
reduc
virul
mean
produc
diseas
infect
host
produc
mild
version
diseas
virus
becom
attenu
origin
host
serial
infect
passag
cell
cultur
differ
organ
case
polio
vaccin
prepar
monkey
cell
infect
embryon
hen
egg
standard
protocol
obtain
attenu
yellow
fever
measl
virus
suitabl
vaccin
prepar
rational
attenu
strategi
due
high
error
rate
replic
virus
especi
rna
virus
viru
accumul
mutat
genom
optim
replic
new
host
new
cell
type
expens
replic
effici
origin
host
attenu
viru
still
compet
replic
retain
abil
infect
host
cell
reason
lav
elicit
differ
effector
mechan
immun
system
intracellular
replic
viru
stimul
cytotox
cell
present
major
histocompat
complex
mhc
class
molecul
particl
releas
outsid
cell
also
present
class
ii
mhc
molecul
immun
lav
immun
system
expos
multipl
antigen
viru
nativ
conform
infect
lav
clear
organ
virusspecif
immun
cell
remain
memori
cell
host
futur
challeng
wild
type
viru
trigger
correct
respons
ie
predominantli
cellular
respons
predominantli
humor
respons
lav
consid
success
vaccin
effici
multipl
stimul
immun
system
typic
induc
potent
durabl
respons
inactiv
vaccin
iv
viral
stock
suscept
inactiv
chemic
physic
treatment
iv
consist
concentr
viral
stock
treat
chemic
reagent
binari
ethylenimin
formaldehyd
complet
abolish
viru
replic
virus
difficult
attenu
may
chang
antigen
properti
remain
virul
passag
cell
cultur
latter
case
fmdv
anim
viru
picornaviru
famili
viru
attenu
suffici
reliabl
inactiv
proven
success
vaccin
strategi
document
fmdv
influenza
hepat
vaccin
secur
issu
may
aris
howev
chemic
compound
reach
viru
particl
exampl
viral
particl
tend
form
compact
aggreg
prepar
still
contain
portion
live
virus
inactiv
virus
usual
effici
present
mhc
class
molecul
stimul
cellular
immun
respons
iv
prepar
includ
adjuv
chemic
compound
act
antigenpres
cell
enhanc
immunogen
vaccin
howev
strength
durat
protect
induc
iv
usual
lower
obtain
lav
recombin
peptidebas
vaccin
great
varieti
vaccin
strategi
catalogu
insid
categori
experiment
recombin
vaccin
produc
express
genet
construct
codifi
viral
peptid
subunit
viru
whole
virus
genet
modif
includ
delet
key
protein
strategi
includ
live
viral
vector
carri
multipl
copi
heterolog
protein
interest
mani
strategi
fail
mainli
low
immunogen
capac
peptid
subunit
compar
whole
live
inactiv
particl
hbv
vaccin
yeastderiv
recombin
vaccin
contain
hepat
b
surfac
antigen
one
viral
envelop
protein
hbv
vaccin
recombin
vaccin
current
approv
use
human
dna
vaccin
strategi
base
inject
dna
construct
directli
host
dna
construct
code
immun
protein
part
interest
viru
transcrib
translat
cell
therefor
express
gene
product
elicit
immun
respons
present
peptid
mhc
class
ii
molecul
influenza
viru
negativestrand
rna
viru
infect
one
fifth
worldwid
human
popul
year
viral
genom
consist
eight
segment
categor
serolog
genet
two
surfac
glycoprotein
neuraminidas
na
hemagglutinin
ha
sever
subtyp
gene
isol
mammalian
avian
host
includ
two
recent
pandem
strain
current
circul
human
popul
respons
hong
kong
flu
swine
flu
respect
influenza
infect
larg
portion
host
popul
everi
season
immun
host
resist
infect
subtyp
expos
sever
year
therefor
select
pressur
exist
viru
diversifi
gener
immunolog
escap
variant
inde
ha
gene
shown
strong
select
pressur
immun
surveil
posit
diversifi
darwinian
select
act
antigendetermin
site
immunogen
part
ha
loci
significantli
nonsynonym
synonym
nucleotid
substitut
observ
rate
evolut
acceler
consider
compar
site
genom
select
also
neutral
genet
drift
seem
play
import
role
evolut
influenza
viru
evolutionari
forc
term
antigen
drift
antigen
shift
observ
human
host
last
centuri
antigen
drift
refer
neutral
evolutionari
chang
accumul
time
wherea
antigen
shift
involv
chang
genet
serolog
properti
viru
due
new
ha
na
subtyp
evolutionari
dynam
epidem
studi
detail
allow
differ
genet
antigen
properti
ha
gene
variat
influenza
subtyp
emerg
replac
everi
year
map
ha
genotyp
antigen
phenotyp
base
neutral
network
model
ie
mutant
organ
connect
phenotyp
ident
cluster
model
explain
observ
pattern
viral
evolut
period
antigen
stasi
episod
cluster
transit
antigen
stasi
popul
drift
neutral
network
divers
increas
hit
boundari
neutral
network
antigen
phenotyp
chang
popul
continu
evolv
new
network
cluster
transit
present
popul
bottleneck
give
rise
select
sweep
reduc
genet
divers
popul
influenza
vaccin
need
redesign
regularli
account
genet
chang
viru
popul
normal
chang
made
respons
antigen
drift
viru
exampl
compon
influenza
vaccin
chang
total
time
select
viral
strain
includ
vaccin
come
season
base
antigen
properti
recent
isol
epidemiolog
data
postvaccin
serolog
studi
human
evolutionari
dynam
influenza
drive
immun
escap
give
rise
new
domin
strain
everi
season
therefor
vaccin
design
support
immunoinformat
method
epitop
predict
also
statist
genet
phylogenet
method
analyz
genet
divers
predict
evolutionari
chang
predict
evolut
influenza
ha
gene
phylogenet
tree
construct
base
dna
sequenc
deriv
virus
year
eighteen
codon
identifi
posit
select
pressur
genet
divers
loci
significantli
higher
loci
ha
gene
rational
predict
next
domin
viru
extant
strain
addit
mutat
loci
better
adapt
evad
host
immun
respons
thu
select
advantag
come
season
phylogenet
analysi
confirm
viral
lineag
greatest
number
mutat
posit
select
codon
ancestor
futur
lineag
influenza
season
approach
predict
evolut
influenza
reli
solv
two
classic
evolutionari
biolog
problem
detect
genet
loci
select
pressur
reconstruct
evolutionari
histori
set
individu
quantifi
rel
contribut
select
versu
random
genet
drift
longstand
task
root
kimura
theori
neutral
evolut
predict
mutat
select
neutral
select
typic
identifi
test
departur
neutral
although
deviat
also
differ
caus
statist
test
either
base
allel
distribut
compar
variabl
differ
class
mutat
tajima
prototyp
test
first
kind
detect
differ
two
distinct
estim
genet
divers
null
distribut
test
statist
obtain
sampl
genealog
accord
coalesc
stochast
process
describ
sampl
variat
similarli
ewenswatterson
test
compar
observ
expect
homozygos
base
ewen
sampl
formula
infiniteallel
model
second
categori
test
fall
mcdonaldkreitman
test
likelihood
ratio
test
base
allel
distribut
nonsynonym
versu
synonym
site
codon
usag
influenza
sequenc
also
analyz
base
codon
volatil
measur
degre
random
nucleotid
mutat
expect
chang
correspond
amino
acid
phylogenet
method
play
import
role
analysi
viral
sequenc
data
use
reconstruct
evolutionari
relationship
differ
viral
strain
three
main
approach
exist
phylogenet
tree
reconstruct
distancebas
method
parsimoni
probabilist
method
base
maximum
likelihood
bayesian
statist
distancebas
method
start
defin
evolutionari
distanc
sequenc
appli
hierarch
cluster
algorithm
obtain
phylogenet
tree
unweight
pair
group
method
arithmet
mean
upgma
averag
linkag
cluster
method
neighbor
join
two
promin
exampl
approach
distancebas
method
comput
effici
reduct
observ
data
distanc
matrix
present
loss
inform
upgma
neighbor
join
reconstruct
correct
tree
strong
assumpt
metric
defin
distanc
matrix
sensit
violat
assumpt
unlik
distancebas
method
characterbas
method
follow
charact
substitut
sequenc
explicitli
maximum
parsimoni
base
minimum
evolut
principl
tri
find
tree
explain
data
minimum
number
mutat
method
appli
success
analysi
influenza
viru
sequenc
data
also
comput
effici
lack
explicit
evolutionari
model
minimum
evolut
statist
consist
hand
probabilist
phylogenet
model
desir
properti
come
comput
cost
usual
render
exact
maximum
likelihood
estim
imposs
howev
approxim
likelihood
method
dnaml
quartetpuzzl
method
make
use
bayesian
infer
mrbay
appli
practic
distancebas
method
probabilist
phylogenet
method
choic
appropri
model
nucleotid
substitut
critic
applic
statist
genet
phylogenet
method
influenza
sequenc
data
improv
understand
evolutionari
dynam
epidemiolog
viru
also
becom
integr
part
yearli
vaccin
design
cycl
howev
success
case
influenza
seem
provid
practic
model
hiv
one
reason
discrep
might
evolutionari
dynam
hiv
strikingli
differ
influenza
rather
driftandshift
pattern
influenza
evolut
gener
small
amount
genet
divers
around
success
trunk
lineag
hiv
tend
spread
ancestor
radial
fashion
gener
much
variat
worldwid
divers
influenza
sequenc
given
year
appear
compar
divers
hiv
sequenc
found
within
singl
infect
individu
one
time
point
thu
hiv
vaccin
must
stimul
broad
reactiv
immun
respons
larg
set
divers
viral
strain
genet
makeup
sequenc
much
difficult
predict
current
circul
strain
compar
influenza
possibl
reason
bioinformaticsassist
vaccin
design
approach
establish
influenza
equal
success
hiv
date
follow
section
discuss
extens
model
discuss
well
complementari
mathemat
comput
approach
might
help
search
hiv
vaccin
futur
evolutionari
escap
hiv
select
immun
pressur
hiv
popul
display
high
genet
divers
due
quasispeci
natur
rna
viru
replic
hiv
occur
three
main
group
princip
group
compos
nine
subtyp
moreov
hiv
great
capac
recombin
among
subtyp
consequ
new
circul
recombin
form
constantli
aris
subtyp
repres
great
genet
divers
well
even
infect
singl
patient
hiv
exist
ensembl
differ
sequenc
high
genet
divers
hiv
popul
hamper
develop
vaccin
broad
applic
vaccin
candid
need
elicit
respons
multipl
epitop
order
counteract
immun
evas
viru
mutat
one
except
attempt
bring
hiv
vaccin
last
phase
clinic
trial
quit
disappoint
far
one
first
promin
vaccin
candid
vaxgen
vaccin
intend
immun
subject
recombin
envelop
protein
hiv
envelop
protein
locat
surfac
hiv
respons
attach
viru
host
cell
surfac
receptor
antibodi
target
protein
could
block
hiv
infect
subsequ
block
viru
entri
cell
vaxgen
trial
immun
induc
product
antibodi
vaccin
individu
unabl
control
infect
viremia
step
vaccin
trial
design
test
effici
cell
vaccin
reduc
viremia
enhanc
cellular
immun
respons
vaccin
candid
therapeut
vaccin
see
intend
enhanc
immun
respons
hiv
even
steril
immun
would
achiev
step
vaccin
formul
base
adenoviru
serotyp
vector
vaccin
includ
three
independ
vector
one
carri
one
three
hiv
protein
gag
pol
nef
although
earli
phase
clinic
trial
vaccin
proven
elicit
specif
antihiv
cell
respons
signific
protect
confer
peopl
receiv
vaccin
phase
iib
trial
inde
individu
immun
memori
vector
suscept
infect
hiv
unexpect
result
probabl
due
addingfueltothefir
effect
vector
activ
cell
creat
suitabl
environ
hiv
replic
recent
combin
vaccin
recombin
canarypox
vector
vaccin
plu
recombin
glycoprotein
subunit
vaccin
test
phase
iii
clinic
trial
thailand
involv
subject
result
show
slight
trend
protect
vaccin
group
compar
control
group
although
number
still
debat
vaccin
affect
degre
viremia
cell
count
hiv
infect
subject
result
offer
insight
futur
research
order
address
challeng
hiv
sequenc
divers
sever
new
vaccin
design
strategi
explor
base
combin
differ
epitop
method
includ
construct
pseudoprotein
string
cell
epitop
synthet
scrambl
antigen
vaccin
combin
consensu
overlap
peptid
set
protein
approach
select
codon
peptid
sequenc
accord
codon
usag
cover
divers
predict
hla
affin
random
sequenc
fragment
vaccin
design
strategi
base
whole
viral
protein
sequenc
make
extens
use
phylogenet
addit
basic
method
discuss
hivspecif
probabilist
model
protein
evolut
construct
allow
improv
phylogenet
infer
use
likelihood
bayesian
method
reconstruct
phylogenet
tree
guid
select
viral
genom
includ
vaccin
differ
select
strategi
propos
stimul
broad
immun
respons
minim
amount
sequenc
diverg
antigen
contemporan
circul
virus
natur
strain
repres
total
observ
sequenc
space
deriv
consensu
sequenc
select
vaccin
strain
probabilist
phylogenet
model
also
allow
infer
dna
sequenc
intern
node
tree
repres
extinct
common
ancestor
recent
common
ancestor
mrca
given
set
virus
root
phylogenet
tree
sequenc
propos
vaccin
strain
stimul
crossreact
immun
respons
descend
howev
asymmetr
phylogeni
consensu
sequenc
mrca
perform
poorli
minim
distanc
contemporari
strain
address
limit
center
tree
node
propos
calcul
node
minim
least
squar
distanc
leav
phylogenet
tree
use
phylogenet
tree
limit
presenc
reticul
evolutionari
event
hybrid
horizont
gene
transfer
recombin
repres
tree
situat
phylogenet
network
model
develop
gener
phylogenet
tree
model
includ
reticul
network
split
network
rna
virus
homolog
recombin
occur
cell
coinfect
two
differ
strain
hiv
multipl
infect
common
recombin
rate
order
time
per
genom
per
replic
cycl
sever
epidemiolog
circul
recombin
form
provid
evid
recombin
hiv
intrahost
evolutionari
dynam
also
shape
recombin
affect
gener
multidrugresist
strain
treat
patient
develop
immun
escap
variant
effici
parsimoni
algorithm
develop
comput
recombin
network
immun
respons
hiv
infect
vari
depend
genet
constel
human
leukocyt
antigen
hla
locu
antigenspecif
cell
immun
hlarestrict
therefor
mutat
hiv
epitop
allow
escap
host
immun
respons
hla
allelespecif
cytotox
lymphocyt
ctl
escap
mutat
shown
stabl
vertic
transmiss
viru
thu
ctl
escap
present
import
drive
forc
shape
hiv
evolutionari
pattern
differenti
hlarestrict
viral
evolut
observ
sever
gene
vaccin
design
point
view
pivot
character
ctl
escap
quantit
order
address
limit
immun
stimul
minim
risk
viral
evolutionari
escap
task
involv
identif
hlaspecif
escap
mutat
predict
mutat
escap
pathway
hiv
polymorph
associ
ctl
escap
leav
hlaspecif
footprint
popul
level
henc
detect
escap
mutat
base
compar
method
howev
least
three
confound
factor
approach
first
viral
sequenc
obtain
differ
host
regard
independ
observ
stochast
process
rather
sequenc
share
common
evolutionari
histori
second
structur
function
limit
biophys
threedimension
protein
structur
impos
constraint
codon
covari
give
rise
linkag
disequilibrium
ld
hiv
genom
third
host
hla
gene
also
ld
close
physic
distanc
human
chromosom
phylogenet
depend
network
pdn
class
probabilist
graphic
model
account
confound
factor
pdn
explicitli
repres
select
pressur
multipl
sourc
model
depend
structur
among
escap
mutat
condit
phylogenet
tree
observ
virus
hla
type
host
analyz
individu
multicent
cohort
statist
model
identifi
dens
network
interact
hla
allel
hiv
codon
well
among
hiv
codon
reflect
complex
also
consist
hiv
adapt
immun
respons
hiv
mutat
pathway
also
model
context
evolutionari
escap
select
pressur
antiretrovir
therapi
sever
probabilist
model
develop
describ
accumul
amino
acid
chang
respons
specif
drug
drug
combin
includ
markov
chain
bayesian
network
mutagenet
tree
conjunct
bayesian
network
cbn
cbn
class
probabilist
graphic
model
describ
order
mutat
occur
model
partial
order
mutat
maxim
likelihood
data
learn
effici
observ
mutat
pattern
cbn
allow
sever
escap
path
differ
probabl
partial
order
restrict
viral
genotyp
space
subset
mutat
pattern
compat
partial
order
constraint
figur
rational
approach
mani
combin
mutat
never
observ
exampl
result
inviabl
virus
far
away
sequenc
space
current
strain
reach
relev
time
scale
cbn
explicitli
repres
timelin
mutat
occur
along
escap
pathway
extend
account
noisi
observ
comput
model
viral
escap
dynam
appli
success
design
optim
combin
therapi
develop
drug
resist
major
factor
treatment
failur
current
resist
profil
also
likelihood
evolv
resist
virus
strong
predictor
therapeut
outcom
difficulti
viru
escap
appli
select
drug
pressur
known
genet
barrier
comput
base
probabilist
model
accumul
mutat
retrospect
analys
larg
observ
clinic
databas
demonstr
estim
genet
barrier
base
viral
progress
model
figur
conjunct
bayesian
network
describ
hiv
evolut
therapi
two
proteas
inhibitor
ritonavir
indinavir
b
vertic
graph
correspond
drug
resistanceassoci
amino
acid
substitut
proteas
stand
chang
lysin
k
arginin
r
posit
etc
direct
edg
graph
denot
partial
order
relat
constrain
mutat
pathway
edg
x
indic
mutat
occur
mutat
x
occur
hcbn
program
ctcbn
softwar
packag
use
gener
model
sampl
ritonavir
indinavir
respect
independ
predictor
treatment
outcom
genet
barrier
improv
therapi
outcom
predict
result
model
outperform
standardofcar
expert
rulebas
treatment
recommend
therefor
comput
model
viral
escap
dynam
might
also
use
vaccin
design
success
hiv
vaccin
minim
distanc
current
circul
strain
also
anticip
possibl
immun
escap
pathway
viru
although
unlik
complet
pictur
escap
pathway
learn
data
improv
term
hinder
delay
escap
might
possibl
especi
context
therapeut
vaccin
select
immun
drug
pressur
togeth
may
constrain
viru
evolut
significantli
result
control
infect
besid
genet
heterogen
develop
effici
vaccin
hiv
remain
elus
difficulti
induc
effici
immun
respons
individu
control
infect
display
strong
cellular
respons
mani
experiment
vaccin
fail
direct
effector
respons
cellular
profil
furthermor
hiv
infect
induc
low
titer
neutral
antibodi
hiv
protein
expos
surfac
virion
protein
respons
attach
hiv
cell
surfac
viru
develop
sever
strategi
avoid
recognit
block
antibodi
region
protein
interact
cellular
receptor
hypervari
loop
great
number
antibodyescap
mutant
map
region
hiv
genom
loop
howev
highli
glycosyl
expos
surfac
protein
precis
moment
interact
cellular
receptor
two
combin
featur
complic
fit
potenti
neutral
antibodi
hiv
member
retroviru
famili
abil
integr
genom
host
cell
genom
genom
integr
anoth
challeng
develop
effect
vaccin
latent
infect
cell
recogn
immun
system
integr
proviru
activ
sever
attempt
obtain
protect
vaccin
hiv
current
effort
shift
toward
develop
therapeut
vaccin
help
control
infect
vaccin
elicit
incomplet
respons
may
suffici
keep
viral
load
control
level
vaccin
would
prevent
infect
hiv
would
delay
prevent
progress
aid
final
stage
diseas
reduct
viral
load
would
also
reduc
number
secondari
transmiss
infect
effici
transmiss
depend
viral
load
level
viral
infect
complex
molecular
process
approxim
major
step
figur
initi
viru
need
find
suscept
cell
enter
insid
cell
viru
replic
start
viral
offspr
releas
infect
cell
eventu
die
releas
viru
particl
either
inactiv
hit
new
suscept
cell
case
infect
cycl
close
chain
reaction
sequenti
infect
trigger
dynam
viral
replic
cycl
express
mathemat
term
follow
ordinari
differenti
equat
ode
system
describ
uninfect
cell
x
infect
effici
b
infect
cell
die
releas
viral
offspr
rate
free
viru
v
produc
rate
k
inactiv
rate
u
absenc
viral
infect
cell
reproduc
rate
l
die
rate
oversimplifi
role
immun
system
immun
cell
z
grow
die
rate
c
b
respect
remov
infect
cell
system
effici
p
specif
viral
famili
may
give
rise
modif
model
due
variat
life
cycl
ode
system
core
famili
mathemat
model
describ
turnov
virus
cell
infect
viru
dynam
model
success
employ
studi
simian
immunodefici
virus
siv
hiv
hbv
among
other
dynam
model
shown
infect
treat
microepidem
host
cell
play
role
infect
suscept
individu
whether
viru
infect
spread
cell
pool
depend
condit
similar
spread
epidem
popul
individu
paramet
model
must
satisfi
inequ
r
r
basic
reproduct
number
defin
number
newli
infect
cell
aris
one
infect
cell
almost
cell
uninfect
cpb
number
given
gener
paramet
r
uninfect
cell
becom
infect
produc
progeni
virus
exponenti
activ
immun
system
reduc
valu
r
slow
spread
infect
begin
infect
immun
respons
mount
initi
peak
viral
load
virus
infect
uninfect
cell
reach
stabl
equilibrium
term
viral
set
point
figur
monitor
viral
load
siv
infect
macaqu
correl
viral
load
initi
stage
infect
viral
set
point
observ
one
demonstr
equilibrium
abund
virus
v
logarithm
viru
load
exponenti
growth
phase
follow
linear
relationship
result
import
hiv
research
sever
studi
indic
posit
correl
viral
load
diseas
progress
individu
display
lower
viral
load
first
stage
infect
higher
chanc
surviv
control
infect
viru
dynam
point
view
success
vaccin
one
boost
immun
respons
ie
increas
paramet
r
reduc
critic
valu
condit
infect
initi
grow
viral
load
rapidli
declin
infect
eventu
clear
organ
howev
even
vaccin
induc
immun
respons
strong
enough
reduc
r
valu
may
still
benefici
describ
slow
initi
exponenti
increas
viral
load
neg
effect
viral
set
point
type
imperfect
vaccin
also
call
therapeut
vaccin
case
hiv
could
help
infect
patient
control
diseas
progress
two
way
first
may
reduc
viral
load
chronic
phase
infect
second
may
reduc
viremia
threshold
interhost
viru
transmiss
figur
epidemiolog
level
mathemat
model
interhost
transmiss
given
viral
pathogen
predict
portion
individu
within
popul
need
vaccin
order
achiev
herd
immun
hi
hi
occur
partial
vaccin
provid
protect
also
unvaccin
individu
popul
protect
invas
pathogen
critic
proport
immun
individu
diseas
persist
hi
threshold
r
basic
reproduct
number
pathogen
host
popul
rather
cell
popul
singl
host
discuss
higher
reproduct
ratio
diseas
individu
need
effect
protect
vaccin
hi
threshold
vari
virul
diseas
also
efficaci
vaccin
contact
dynam
host
popul
individu
virus
insid
quasispeci
display
differ
degre
virul
trait
measur
cell
kill
capac
consid
cell
cultur
experi
host
morbid
mortal
focus
wholeorgan
patholog
replic
fit
also
highli
variabl
among
virus
quasispeci
gener
directli
correl
virul
understand
evolut
two
viral
trait
fundament
understand
control
spread
viral
diseas
design
lav
sinc
attenu
virus
may
elicit
potent
immun
respons
without
caus
harm
host
sever
strategi
explor
obtain
candid
virus
lav
ie
virus
display
reduc
cell
kill
replic
abil
serial
cytolyt
transfer
cell
cultur
tend
select
virus
attenu
origin
host
case
fmdv
yellow
fever
viru
among
virus
current
approv
techniqu
sever
lav
prepar
virus
select
sever
bottleneck
serial
plaquetoplaqu
transfer
present
reduc
fit
due
accumul
mutat
associ
ratchet
effect
new
promis
strategi
attenu
virus
ration
design
synthesi
viral
genom
strong
codon
bia
approach
implement
polioviru
influenza
viru
viral
genom
synthes
encod
amino
acid
sequenc
wild
type
viru
encod
infrequ
codon
host
cell
virus
harbor
fidel
mutat
replicas
gene
tend
produc
quasispeci
lower
divers
attenu
vivo
featur
also
employ
ration
design
polioviru
lav
strategi
conceiv
limit
viral
replic
includ
design
specif
microrna
zinc
finger
nucleas
target
viral
genom
mani
mathemat
model
develop
describ
evolut
virul
divers
viral
popul
one
conclus
theoret
studi
virul
increas
popul
varieti
condit
basic
model
viru
dynam
howev
state
less
cytopath
variant
product
long
term
infect
abund
virus
infect
cell
invers
correl
cytopathogen
viral
variant
r
recent
fmdv
popul
report
diversifi
two
genet
distinct
subpopul
also
differ
virul
viral
variant
character
phenotyp
consider
detail
coevolutionari
dynam
compet
cell
pool
vitro
analyz
competit
experi
describ
extens
basic
model
viru
dynam
introduc
experiment
theoret
result
indic
less
virul
strain
effici
outcompet
virul
one
coinfect
cell
therefor
fit
variant
differ
virul
densitydepend
cell
competit
model
offer
explan
sever
previou
observ
suppress
high
fit
mutant
dissimilar
viral
system
densitydepend
select
due
vari
effici
viral
replic
alon
coinfect
reminisc
concept
competitioncolon
tradeoff
ecolog
virul
viral
variant
play
role
colon
virus
effici
within
coinfect
cell
competitor
attenu
effect
competitorcolon
competit
appear
even
pronounc
mani
virus
broad
spectrum
virul
consid
viral
evolut
genet
divers
produc
fundament
factor
success
vaccin
candid
immun
respons
need
stimul
potenti
broad
spectrum
exist
virus
new
viral
immun
escap
variant
like
gener
mathemat
model
viral
evolutionari
dynam
therefor
play
increasingli
import
role
vaccin
design
identifi
genom
region
select
pressur
support
select
construct
vaccin
strain
predict
evolutionari
escap
immun
pressur
guid
vaccin
campaign
estim
effect
therapeut
vaccin
support
design
new
attenu
strategi
discuss
context
rna
virus
mani
issu
pronounc
class
virus
nevertheless
expect
statist
model
comput
method
applic
virus
differ
pathogen
hand
distinct
evolutionari
dynam
influenza
two
wide
studi
rna
virus
highlight
need
care
analysi
viral
infect
dynam
within
among
individu
list
abbrevi
use
hiv
human
immunodefici
viru
hcv
hepat
c
viru
hvb
hepat
b
viru
rsv
respiratori
syncyti
viru
siv
simian
immunodefici
viru
fmdv
footandmouth
diseas
viru
adenoviru
serotyp
vector
lav
live
attenu
vaccin
iv
inactiv
vaccin
na
neuraminidas
ha
hemagglutinin
mhc
major
histocompat
complex
upgma
unweight
pair
group
method
arithmet
mean
mrca
recent
common
ancestor
ctl
cytotox
lymphocyt
hla
human
leukocyt
antigen
ld
linkag
disequilibrium
pdn
phylogenet
depend
network
cbn
conjunct
bayesian
network
ode
ordinari
differenti
equat
hi
herd
immun
